Certain antibodies that pass through the placenta are associated with improved survival of infants who acquire HIV through nursing.

Thursday, Nov. 30, 2023 Antibodies Passed through Placenta May Improve Survival for Infants with HIV Caption: Colorized transmission electron micrograph of two HIV-1 virus particles (yellow) budding from the plasma membrane of an infected H9 T cell (blue). Image captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. (Credit: NIAID) A Kenya-based study found certain antibodies that pass through the placenta are associated with the improved survival of infants who acquire HIV through nursing. The study observed that preexisting antibodies that target a region of a protein on HIV's surface were correlated with delayed HIV acquisition in infants exposed to the virus as well as a lower amount of virus circulating in the blood of infants who acquired HIV. . National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107